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Ol lwr, The purpose of dais study was to assess the relation
between the t me of awakening and the time of onset of acute
rrYeesrdW WWcdoa .
Me igi i 14 Previous investigation has shown the onset
of
symphms of acute myocaardlal htsrction to have a primary peak
1 to 2 h off awakening. In studies not corrected for time of
awakeein, there appears to be a late allernoon/early evening
peals,, bet data eeawla leg the onset of symptoms with awakening
have bee, MW by said numbers of patients, perhaps preclud.
he filludlilledles of a secondary peak .
MAO&
Iu the Cardiac Arrhythmia Suppression Trial
(CAST), 3,349 patients had a documented myocardial infarction
and entered ant yhmle titration. of these, 3,304 had
data on the onset of symptoms relative to the dose of awakening
and form the basis of this report.
Aitu#t. A total of 870 patients (26 .3%) were awakened by
Circadian rhythms have been demonstrated in the onset of
acute cardiovascular events, especially acute myocardial
in tion, ventricular tachycardla, sudden cardiac death,
cerebrovascular accident and fatal pulmonary thromboem-
bolism (1-8), In most studies of acute myocardial infarction,
the onset of symptoms has been demonstrated to peak either
in midmorning or in late afternoon and early evening, or at
both of these times. Few studies have correlated events with
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symptoms. Of the rem laing 2,439 patients who were not awak-
ened by symptoms, 798 (32.7%) experIenced the onset of symp-
toms in the 1st 4 h titer awakening (with the highest number in the
1st h), alter which the Incidence of symptom onset decreased In a
linear fashion, with a secondary peak 11 to 12 h after awakening .
Both peaks are statistically significant . A similar pattern was seen
In most of the subgroups examined (based on age, gender and
various other demographic character
	
).
Cone z rlons. Analysis of the very Gage CAST data base
confirms tine relation between awakening and onset of symptoms
of myocardial Infarction, suggesting Involvement of the morning
catecholamine surge. A secondary peak In symptom onset, occur-
ring 11 to 12 h after awakening, Is a new observation and may
relate to Ingestion of the evening meal or other trigger factors
concentrated In those hours .
(J Am Cold Candid 1993 ;22:998-1003)
specific time of awakening . Ascertaining the relation be-
tween symptom onset and awakening has major pathophys-
iologic and therapeutic implications . Previous studies (9,10)
related to time of awakening have been limited by the small
number of patients (a combined total of 361), precluding
meaningful subgroup analysis .
The Cardiac Arrhythmia Suppression Trial (CAST) was
initiated to determine whether suppression of asymptornatic
ventricular ectopic activity after myocardial infarction by
means of antiarrhythmic drugs would reduce the incidence
• arrhythmic death (11,12). The present analysis uses the
large CAST data base to test the hypothesis that the previ-
ously described circadian variation in the onset of symptoms
• acute myocardial infarction relates to the time of awak-
ening. Additionally, it is our aim to determine whether this
relation remains constant in a variety of patient subgroups .
Methods
The institutional Committee on Human Research ap-
proved the study protocol in all participating institutions .
Written informed consent was obtained from all subjects . A
detailed description of the CAST methodology has been
provided elsewhere (11,12). The following is a brief review
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of the more important a-pects of the trial, with more detailed
information in the areas relevant to the present analysis .
Patients. Patients <80 years of age were eligible if they
demonstrated an average of L-6 ventricular premature depo-
larizations/h on baseline 24-h ambulatory electrocardio-
graphic (ECG) Holter monitoring and had an ejection frac-
tion s55% within 90 days or s40% within 2 years of a
documented acute myocardial infarction (see Appendix) .
Specifically excluded were patients with a :15 consecutive
beats of ventricular tachycardia at a rate of ?120 beatslmin
>6 days after infarction, symptomatic bradycardia (without
a permanent pacemaker), New York Heart Association
functional class IV congestive heart failure, chronic renal
failure or other conditions likely to limit life span . Also
excluded were patients receiving other antiarrhythmic drugs
of the sodium channel blocking class and those with con-
traindications to any of the study drugs .
After the 1st 22 months of the study, eligibility criteria
were altered as follows : 1) the upper limit of left ventricular
ejection fraction was lowered to s40% for all patients ; 2) the
time from the qualifying myocardial infarction to the quali-
fying Holter ECG was shortened to s90 days; and 3) the
definition of disqualifying ventricular tachycardia was liber-
alized, allowing patients with up to 30 s of ventricular
tachycardia to enter the trial if their arrhythmia was asymp-
tomatic.
Before starting study drugs, ;i.t patients underwent a
baseline history and physical examination . Patients were
specifically questioned, usually by the nurse-coordinator,
about the timing of onset of qualifying myocardial infarction
symptoms relative to the time of awakening on that day (to
the nearest hour) . Symptoms considered typical for acute
myocardial infarction included severe discomfort anywhere
in the anterior chest, back, neck or shoulder for ?30 min,
frequently associated with nausea, vomiting, diaphoresis or
dyspnea.
Statistical methods. In general, sine or cosine curves
were used to model circadian patterns over time for the
occurrence of a particular event. In this study, we are
concerned with the time after awakening that myocardial
infarction occurs rather than the absolute time of day .
Because the time of increased physical activity required on
awakening will track each subject's time of arising, the
absolute time of symptom onset was not part of the data
base, and because zero hours does not mean the same thing
as 24 It after awakening, a cyclic function such as the cosine
curve is not applicable in our setting .
To assess the relation between time of awakening and
onset of symptoms of myocardial infarction, a chi-square
goodness of fit test was used to ascertain whether the
distribution of events is uniform over time (13) . Patients who
were awakened by symptoms were not included in the
analysis. Hours after awakening were grouped into 2-h
periods to minimize recall bias because there was a tendency
to report even rather than odd numbers for events that
occurred >4 h after awakening. Because the frequency of
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events is expected to decrease after 12 h, and there is an
unusual peak at I I to 12 h, we only tested whether the events
in the 1st 10 h after awakening were uniformly distributed
(this approach is conservative in the sense that it will reduce
the statistical significance of the results)
. A second analysis
was performed using the extended time period of I to 16 h .
We determined whether the number of events in each 2-h
interval was consistent with a uniform fit . This was accom-
plished by assuming a multinomial distribution with equal
expected number of events per interval and computing a z
score for each 2-h interval (i .e ., we subtracted the expected
number of counts from the actual number of counts and
divided this difference by the theoretic standard deviation) .
To investigate the significance of the secondary peak
approximately 12 h after awakening, we tested whether the
onset of the event is uniformly distributed in a 16-h period
(the usual wake cycle) . Specifically, we used the chi-square
goodness of fit test on three 2-h periods : 9 to 10, 11 to 12 and
13 to 14. To judge the significance of the p value, we
multiplied it by a factor of 6 to take into account the fact that
we used the observed location of the secondary peak and
that there are six possible peaks to observe . Differences in
event distribution between patient subgroups were tested by
the standard chi-square test for two-way contingency tables
(excluding patients who were awakened by symptoms) .
Results
A total of 3,549 patients had a qualifying myocardial
infarction and began drug titration . Of these, 240 (7%) were
omitted from analysis because of incomplete data or because
the time of onset of symptoms could not be determined to
the nearest hour. The remaining 3,309 patients (2,215 from
the first phase of CAST and 1,094 from the second phase)
form the basis of this report . The study group was 82% male,
with a mean age of 61 .7 years . Forty-three percent had had
a myocardial infarction before the CAST qualifying myocar-
dial infarction, 22% had a history of diabetes mellitus, 3296
had a history of hypertension and 40% were smokers at the
time of their qualifying myocardial infarction. Table I and
Figure 1 show, grouped by 2-h intervals, the distribution of
onset of symptoms of acute myocardial infarction in the
entire group . Slightly >25% were awakened by the onset of
symptoms, and approximately the same number had the
onset of symptoms within 4 h of awakening, with the highest
number in the Ist h . A., lesser peak is seen I1 to 12 h after
awakening, where the hourly frequency approaches that
seen in hs 3 and 4. After 14 h, the frequency drops off
sharply . When event onsets are grouped in 2-h intervals, and
events during h I to 10 are analyzed using the chi-square
goodness of fit test, the distribution is nonuniform (chi
square = 65 .32, with 4 degrees of freedom (dO, p < 0
.0005)
(Table 1)
. Wheno we examined the z scores for the individual
2-h intervals between h I and 16, we found that all but two
intervals (h 5 to 6 and 7 to 8) are significantly different from
the uniform fit (Table 2)
. Significantly more events occurred
sofMls
to s4 a, 74 9-111
11.12 M14 III-is 3.19
Hours from Awakalng t o Acute MI Synilpfeo Onset
in intervals I to 2 h, 3 to 4 h and t I to 12 h compared with the
uniform estimate, and significantly fewer events occurred in
intervals 9 to 10 h,13 to 14 h and 15 to 16 h . The fact that the
number of events in the 1 l- to 12-h interval is significantly
larger (p - 0.0008), whereas the number of events in the
intervals on either side of I I- to 12 h is significantly smaller
(p
-
0.0021 and p < 0.0005, respectively), indicates that the
peak at 12 h is not a spurious observation but an important
feature of this data set . Moreover, using the small window
at -12 h, the peak at 12 h is statistically significant (chi-
square = 41 .59, with 2 df, adjusted p < 0.0005) .
Subgroup analysis. The data were examined in a number
of patient subgroups on the basis of availability of informa-
tion. Specifically, information about medication being taken
at the time of the acute infarction was not routinely obtained
and was unavailable for this analysis. Accordingly, we
performed subgroup analysis on the basis of age, gender,
previous myocardial infarction, presence or absence of Q
waves and history of congestive heart failure, diabetes
mellitus and smoking up to the time of myocardial infarction .
All subgroups displayed a pattern similar to the total group .
In all but one, the chi-square goodness of fit test revealed
l%ee I. Graphic representation of the relation between the time of
awakening and the onset of symptoms of the Cardiac Arrhythmia
Suppression Trial qualWng myocardial infarction (MI) .
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nonuniform distribution (p < 0.05). The only exception was
the subgroup with congestive heart failure, and the lack of
statistical significance here was probably due to the small
sample size (15% of the total group) .
The secondary peak seen at 12 h was particularly prom-
inent in patients >65 years old (adjusted p < 0 .001) (Fig. 2,
second panel) and in patients with a history of previous
myocardial infarction (adjusted p < 0.001) (Fig. 2, third
panel) but was not statistically significant among patients
<55 years of age (adjusted p = 0.66). With regard to gender,
the two peaks were fairly prominent in both men and women
(Fig. 2, top panel) but were not statistically significant in
women (adjusted p = 0.12), probably because of the small
sample size. Among patients with a previous myocardial
infarction, the peak in the 1st 4 h is less prominent than that
in patients with no previous myocardial infarction. The
distributions for these two groups are significantly different
(chi-square = 17 .58, 8 df, p = 0 .025); however, none of the
other differences between groups are statistically significant
using a Pearson chi-square statistic .
Finally, to assess the possibility that data recall could
have influenced our results, we analyzed our data according
to whether or not patients were interviewed within 30 days
of the acute event. We found no major differences between
these two groups. Twenty-six percent of the patients were
interviewed within 30 days and, although fewer reported
symptom onset exactly 12 h after awakening, both groups
demonstrated the secondary peak such that there is a clear
increase in event rate beginning at 9 h and ending at 12 h
(Fig. 2, bottom panel) .
Discussion
Our results provide convincing evidence (using a large
patient data base) that the time of onset of acute myocardial
infarction is related to the time of awakening. We found that
approximately 25% of patients were awakened by symptoms
and that another 25% had symptom onset within 4 h of
awakening, (the greatest number in the 1st h). Our observa-
tions are similar to those in previous studies involving fewer
subjects but are different in identifying a secondary peak 11
l'000
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Table 1
. Frequency Distribution of Onset of Symptoms of
Myocardial Infarction Related to Time of Awakening
Table 2 . z Scores and p Values for Each 2-Hour Interval Testing
for a Uniform Fit
Hours From
Patients
Hours From
Awakening Events z Score P Value
Awakening No.
90
8.715 < 0.00051-2 433
Awakened
870 26.3
3-4 365 4.470 < 0.0005
2 433 13.1
5-6 309 0.975 0.3294
3-4 365 11 .0
7-8 288 -0.336 0.7373
5-6 309 9.3
9-10 244 -3.082 0.0021
7-8 288 8.7
11-12 347 3.347 0.0008
9-10 244 7.4
13-14 203 -5.641 < 0.0005
11-12 347 10.5
15-16 ]is -8.449 < 0.0005
13-14 203 6.1
Total 2,347
15-16 158 4.8
>16 92 2.8
Total 3 .309 100.0
JACC Vol . 22, No . 4
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Figure 2 . The frequency distribution of the onset of acute
myocardial infarction with patients grouped accordin ; to
age, gender, history of previous myocardial infarction and
length of time of the baseline interview from the qualifying
myocardial hifarction . MI = myocardial infarction .
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Pe~ M
Group
to 12 h after awakening (9,10) . Secondary peaks have been
described previously, especially in certain subgroups, but iE!
these reports, the onset of symptoms had not been adjusted
for the time of awakening (1,2) . In general, the frequency
distribution of the subgroups that we examined was similar
to that of the entire study group .
Possible mechanisms, It is of interest to speculate on the
pathophysiology underlying our findings . The morning peak,
in common with sudden cardiac death and other acute
events, has been attributed to a morning increase in cate-
cholamines and accompanying changes in heart rate, blood
pressure, platelet aggregability, vascular tone and clotting
factors (14-16) . It is possible that the secondary peak at I I to
12 h is partly due to reporting bias; however, a similar
pattern was apparent in virtually all subgroups, although this
25
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peal, did not achieve statistical significance in all. If this
sect .dary peak is real, the mechanism has been less com-
ptei rly explored. If it is assumed that our study group is
similar to that described by Goldberg et al . (9) :and that the
average person ii+ our studs awakened between 6 AM and
8 AM, then the secondary peak would fall between 6
PM and
8 PM. We speculate that this period may represent the
confluence of several trigger factors not present earlier in
the day, such as the formal gathering of the family unit and
the evening meal, which is generally the largest meal of the day
and one that is relatively rich in saturated fat . Although this
secondary peak is smaller than the primary morning peak, it
may be more amenable to future investigation because the
transition from sleep to wakefulness is not occurring, and
potential trigger factors may be more readily identified.
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St* %mitalions
. Our data should be interpreted in light
of several methodologic limitations . Although this substudy
was
Alai-.;red
prospectively to explore the
relation between
awakening and the onset of symptoms, the information was
u&rained at the time of the baseline examination, which may
have occurred as long as 2 years after the qualifying myo-
cardial infarction. This delay presents a number of potential
biases
. 1) It excludes patients who died of the infarct or of
another cause or who developed some other exclusion
criterion (sustained ventricular tachycardia, renal failure, for
example). Thus, our data may only apply to a select popu-
latlon of survivors, 2) Although it is possible that the patients
who were interviewed a longer time after the acute infarction
might not remember the time of onset of symptoms accu-
rately, there were no significant differences betwet ;n those
patients who were interviewed within 30 days of their
myocardial infarction and those who were not . The presence
of the 12-h peak in both groups supports the theory that the
12-h peak is not a result of reporting bias but is due to a true
secondary mode in the event rate . 3) We have no information
with regard to the type of medication that people were
receiving at the time of the acute infarct . Relatively few
patients (30%) were receiving beta-adrenergic blocking
agents, a class of medications known to affect circadian
rhythms (1, 17,18), at the time of the baseline examination .
Similarly, we have no information about the use of salicy-
lates, also recently shown to affect the time of onset of acute
myocardial infarction (19) . However, it is likely that even
fewer patients were receiving them before their acute infarc-
tion, and the effects of these drugs would blunt rather that
strengthen the observed curve .
Because our study was designed to assess the relation
between awakening and symptom onset, the actual time of
day was not routinely recorded. Although it can be argued
that the addition of this information to our data base might
have been helpful, we consider that the time of day of
myocardial Mtaretion onset has been well documented pre-
viously (1,2) . Studies by several investigators suggest that
changes associated with arising and initiating daily activities
may be more important from a pathophysiologic standpoint
than the actual tune of day (14,20,21) .
Another potential limitation is the assumption, for study
purposes, that the onset of symptoms is synonymous with
the onset of the event, In certain patients, such as those with
prolonged episodes of pre- or postin1hrction angina, the
actual initiation of necrosis may not be apparent without
hourly serum enzyme determinations . However, in the
mjority, the onset of symptoms was relatively well de-
fined, and it is unlikely that this problem would produce
any systematic bias. Furthermore, it has been previously
tented that the onset of symptoms correlates well with
the eazymatically determined onset of myocardial infarction
(U .
Couclusiess. Our study utilized the CAST data base to
examine the relation between awakening and onset of symp-
toms in >3,000 patients with documented acute myocardial
infarction . We found a prominent peak within 4 h of awak-
ening, greatest in the 1st h, and a secondary peak 11 to 12 h
after awakening. This pattern extended across most sub-
groups examined. Further work is needed to more fully
investigate the role of specific trigger factors in the onset of
acute myocardial infarction and to help elucidate the patho-
physiology of our findings . Investigations designed to ex-
plore the role of these trigger factors are currently underway
and should lead to the development of improved therapeutic
strategies (22) .
Appendix
CAST Qualifying Myocardial Infarction
The diagnostic criteria used to determine whether a myocardial
infarction qualified for entry into the Cardiac Arrhythmia Suppres.
sion Trial (CAST) included symptoms, cardiac enzymes and elec-
trocaldiographic (ECO) changes . Myocardial infarctions were di-
vided into five classes according to the following criteria .
Class 1. Typical symptoms and either 1) enzyme criteria or
2) new pathologic Q waves in two contiguous leads
Class Il. Atypical symptoms and either 1) new pathologic Q
waves in two contiguous leads or 2) enzyme criteria with new
abnormal ST-T changes or 3) creatine kinase MB fraction (CK-MB)
>596
Class M . Asymptomatic and either 1) new pathologic Q waves in
two contiguous leads (compared with a previous ECG in the past 2
years without the pathologic Q waves) or 2) CK-M .B fraction >5
Class IV. Myocardial infarction L-5 days after cardiac surgery,
with two of three of the following : 1) typical symptoms, 2) ECG with
new pathologic Q waves in two coat guous leads (compared with
initial postoperative ECG), 3) CK-ME fraction >5%
ClamV. Myocardial infarction s2 t ays after noncardiac surgery,
with any of the following; t) ECU wig h new pathologic Q waves in
two contiguous leads (compared wit]
,
initial postoperative ECG),
2) total CK a 1 .5 times the upper limit of normal and ECG with
evolving abnormal ST-T wave change 1, 3) CK-MB fraction >5%
CAST enzyme criteria were sails led by any of the following:
I) Total CK-MB 21 .5 times the upper limit of normal, 2) CK-MB
fraction >5%.3) lactate dehydrogenas,; (LDH) a 1 .5 times the upper
limit of normal and LDH, > LDH 2 , 4) serum g(utamic oxaloacetic
transaminase (aspartate aminotransferase) y3 times the upper limit
of normal
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